The cost of CIED infectious complications treatment in Poland from the perspective of Polish hospitals.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2022
Historique:
received: 25 05 2022
accepted: 25 05 2022
pubmed: 15 6 2022
medline: 12 10 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Cardiac implantable electronic devices (CIED) are a recognized form of therapy in cardiology. Apart from the benefits, the use of CIEDs is also associated with the risk of complications, and the most important ones influencing treatment results and prognosis are infectious complications. This study aimed to calculate the cost of treatment of CIED-related infections, including transvenous lead extraction and device reimplantation, from the perspective of a Polish hospital. A retrospective analysis of hospitalization costs of patients referred to transvenous lead extraction (TLE) for CIED infection was performed. The study covers cases from three Polish reference centers specializing in the comprehensive treatment of cardiac electrotherapy complications. It was shown that the average cost of treating a CIED infection is 34 000 PLN (8010 EUR) and is the highest in the cardiac resynchronization therapy with defibrillator function (CRT-D) group, where it amounts to almost 50 000 PLN (11 440 EUR). Thus, treatment of CIED infections is associated with an average loss of 3000 PLN for the healthcare provider and the length of hospitalization has a major influence on final outcomes. The hospital cost of treatment of CIED-related infections was high and related mainly to the type of device and length of hospitalization. Despite the low utilization of costly extraction tools, the hospitalization was still likely to be unprofitable.

Identifiants

pubmed: 35698969
pii: VM/OJS/J/90248
doi: 10.33963/KP.a2022.0144
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

919-925

Auteurs

Janusz Romanek (J)

Department of Cardiology with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No. 2, Rzeszów, Poland.
Medical College, University of Rzeszów, Rzeszów, Poland.

Michał Farkowski (M)

2nd Department of Heart Arrhythmia, National Institute of Cardiology, Warszawa, Poland.

Hubert Bukowski (H)

Institute of Innovation and Responsible Development, Warszawa, Poland.

Krzysztof Gołba (K)

Department of Electrocardiology and Heart Failure, Upper Silesian Heart Center, Medical University of Silesia, Katowice, Poland.

Krystian Wita (K)

1st Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia Katowice, Poland.

Przemysław Mitkowski (P)

1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.

Andrzej Przybylski (A)

Department of Cardiology with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No. 2, Rzeszów, Poland. a_przybylski-65@wp.pl.
Medical College, University of Rzeszów, Rzeszów, Poland. a_przybylski-65@wp.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH